Defiance Daily Target 2X Long NVO ETF (NVOX)

NYSEARCA: NVOX · Real-Time Price · USD
12.49
+0.01 (0.08%)
At close: Apr 28, 2026, 4:00 PM EDT
12.41
-0.08 (-0.64%)
After-hours: Apr 28, 2026, 5:29 PM EDT
Assets$43.86M
Expense Ratio1.30%
PE Ration/a
Shares Out3.26M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume635,978
Open12.60
Previous Close12.48
Day's Range12.45 - 13.02
52-Week Low9.23
52-Week High72.16
Betan/a
Holdings12
Inception DateDec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NYSEARCA
Ticker Symbol NVOX
ETF Provider Defiance

Top 10 Holdings

287.49% of assets
NameSymbolWeight
NOVO-NORDISK SWAP MSn/a64.80%
US DOLLARSn/a40.75%
OTHER ASSETS AND LIABILITIESn/a34.32%
NOVO-NORDISK INC SWAP CANTORn/a25.62%
NOVO-NORDISK SWAP CLEARSTREETn/a25.19%
NOVO-NORDISK A/S-SPONS ADR NOMURAn/a24.37%
NOVO-NORDISK SWAP NBC-Ln/a23.12%
NOVO-NORDISK SWAP MAREXn/a22.19%
NOVO-NORDISK SWAP BMO-Ln/a18.07%
First American Government Obligations FundFGXXX9.06%
View More Holdings

Performance

NVOX had a total return of -71.27% in the past year, including dividends. Since the fund's inception, the average annual return has been -84.18%.

News

Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk

MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss marke...

Other symbols: NVO
1 year ago - GlobeNewsWire